Palmetto Pharmaceuticals' Series E - II Round

Palmetto Pharmaceuticals raised a round of funding on January 26, 2006.

Palmetto Pharmaceuticals (formerly eNOS Pharmaceuticals) has developed products that improve and restore blood flow and to reduce triglycerides through up-regulation of endothelial nitric oxide syntha…

Articles about Palmetto Pharmaceuticals' Series E - II Round: